• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体噬菌体治疗的临床前数据和安全性评估。

Preclinical data and safety assessment of phage therapy in humans.

机构信息

Department of Genetics and Genome Biology, University of Leicester, University Road, LE1 7RH, UK.

Department of Genetics and Genome Biology, University of Leicester, University Road, LE1 7RH, UK.

出版信息

Curr Opin Biotechnol. 2021 Apr;68:310-317. doi: 10.1016/j.copbio.2021.03.002. Epub 2021 Apr 13.

DOI:10.1016/j.copbio.2021.03.002
PMID:33862490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8150739/
Abstract

Bacteriophages (phages) are natural biological entities that kill bacteria with species specific precision, rendering them attractive for therapeutic purposes. Phages were discovered over a century ago, but, after antibiotic discovery, their use as antimicrobials dwindled. Interest in phage therapy has, however, been rekindled by increasing multi-drug resistance to routine and frontline antibiotics and by the slowing of antibiotic innovations. To build on fundamental phage research studies and compassionate usage, information on safety and efficacy of phages is needed to motivate clinical trials and are necessary for phage therapy to become mainstream. In this review, we discussed essential phage characterisation parameters alongside the merits and limitations of state-of-the-art models to gather preclinical data on the safety and efficacy of phage therapeutics.

摘要

噬菌体(phages)是一种能够精准杀死特定细菌的天然生物实体,因此在治疗方面具有很大的吸引力。噬菌体早在一个多世纪前就已被发现,但在抗生素被发现后,它们作为抗菌药物的用途逐渐减少。然而,由于常规和一线抗生素的耐药性不断增加,以及抗生素创新速度放缓,人们对噬菌体疗法的兴趣又重新燃起。为了在基础噬菌体研究和同情使用的基础上更进一步,需要获得有关噬菌体安全性和有效性的信息,以推动临床试验的开展,这对于噬菌体疗法成为主流是必要的。在这篇综述中,我们讨论了噬菌体特征描述的基本参数,以及最先进的模型的优缺点,以收集噬菌体治疗安全性和有效性的临床前数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ede/8150739/cafceb325129/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ede/8150739/8cfcc13c6f59/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ede/8150739/cafceb325129/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ede/8150739/8cfcc13c6f59/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ede/8150739/cafceb325129/gr1.jpg

相似文献

1
Preclinical data and safety assessment of phage therapy in humans.人体噬菌体治疗的临床前数据和安全性评估。
Curr Opin Biotechnol. 2021 Apr;68:310-317. doi: 10.1016/j.copbio.2021.03.002. Epub 2021 Apr 13.
2
Phage therapy for respiratory infections.噬菌体疗法治疗呼吸道感染。
Adv Drug Deliv Rev. 2018 Aug;133:76-86. doi: 10.1016/j.addr.2018.08.001. Epub 2018 Aug 7.
3
Back to the future: bacteriophages as promising therapeutic tools.回到未来:噬菌体作为有前景的治疗工具
HLA. 2016 Mar;87(3):133-40. doi: 10.1111/tan.12742. Epub 2016 Feb 19.
4
The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.噬菌体及其裂解酶的临床前和临床进展:整体比部分更难。
Viruses. 2019 Jan 24;11(2):96. doi: 10.3390/v11020096.
5
Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.噬菌体疗法作为人类感染的一种替代治疗方法。全面综述。
Int J Antimicrob Agents. 2019 Jan;53(1):16-21. doi: 10.1016/j.ijantimicag.2018.09.004. Epub 2018 Sep 17.
6
[Phage therapy, an alternative to antibiotic therapy?)].[噬菌体疗法,抗生素疗法的替代方案?]
Rev Esp Quimioter. 2018 Apr;31(2):101-104. Epub 2018 Feb 16.
7
Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.噬菌体疗法作为应对抗生素后时代的策略:初学者及专家指南
Arch Microbiol. 2021 May;203(4):1271-1279. doi: 10.1007/s00203-020-02167-5. Epub 2021 Jan 20.
8
Phage Therapy for Antibiotic-Resistant Bacterial Infections.噬菌体疗法治疗抗生素耐药性细菌感染
Annu Rev Med. 2022 Jan 27;73:197-211. doi: 10.1146/annurev-med-080219-122208. Epub 2021 Aug 24.
9
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?噬菌体疗法在耐药时代:我们的现状与未来走向
Clin Ther. 2020 Sep;42(9):1659-1680. doi: 10.1016/j.clinthera.2020.07.014. Epub 2020 Aug 31.
10
[Phage therapy, an additional strategy against multidrug-resistant bacteria].[噬菌体疗法,一种对抗多重耐药菌的额外策略]
Rev Med Liege. 2022 Sep;77(9):510-515.

引用本文的文献

1
Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.噬菌体和溶菌酶治疗耐药细菌:从实验室到临床应用
MedComm (2020). 2025 Jul 13;6(7):e70280. doi: 10.1002/mco2.70280. eCollection 2025 Jul.
2
Evolutionary dynamics and research hotspots of phage applications against infections from the past to the new era.从过去到新时代噬菌体抗感染应用的进化动力学与研究热点
Front Microbiol. 2025 Jun 24;16:1606351. doi: 10.3389/fmicb.2025.1606351. eCollection 2025.
3
Large-Scale Genomic Analysis of CpG-Mediated Immunogenicity in Bacteriophages and a Novel Predictive Risk Index.

本文引用的文献

1
Rethinking Phage Ecology by Rooting it Within an Established Plant Framework.通过将噬菌体生态学植根于既定的植物框架中来重新思考它。
Phage (New Rochelle). 2020 Sep 1;1(3):121-136. doi: 10.1089/phage.2020.0015. Epub 2020 Sep 16.
2
Phage steering of antibiotic-resistance evolution in the bacterial pathogen, .噬菌体对细菌病原体抗生素耐药性进化的引导 , 。(你提供的原文似乎不完整)
Evol Med Public Health. 2020 Jul 11;2020(1):148-157. doi: 10.1093/emph/eoaa026. eCollection 2020.
3
Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy.
噬菌体中CpG介导的免疫原性的大规模基因组分析及一种新型预测风险指数
bioRxiv. 2025 May 16:2025.05.15.652987. doi: 10.1101/2025.05.15.652987.
4
Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects.噬菌体治疗人类、动物和植物中的多重耐药细菌感染:现状与未来前景。
Infect Med (Beijing). 2025 Feb 5;4(1):100168. doi: 10.1016/j.imj.2025.100168. eCollection 2025 Mar.
5
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.一种新分离的噬菌体对耐多药粪肠球菌感染的治疗潜力:体外和体内特性研究
BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z.
6
Phage therapy could be key to conquering persistent bacterial lung infections in children.噬菌体疗法可能是攻克儿童持续性肺部细菌感染的关键。
NPJ Antimicrob Resist. 2024 Oct 10;2(1):31. doi: 10.1038/s44259-024-00045-4.
7
Translational research priorities for bacteriophage therapeutics.噬菌体疗法的转化研究重点
Essays Biochem. 2024 Dec 17;68(5):621-631. doi: 10.1042/EBC20240020.
8
Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections.对抗临床医疗保健相关感染中形成生物膜病原体的当前策略
Indian J Microbiol. 2024 Sep;64(3):781-796. doi: 10.1007/s12088-024-01221-w. Epub 2024 Apr 8.
9
Bacteriophage therapy- a refurbished age-old potential strategy to treat antibiotic and multidrug resistant bacterial infections in future.噬菌体疗法——一种经过翻新的古老潜在策略,有望在未来治疗抗生素和多药耐药菌感染。
Braz J Microbiol. 2024 Sep;55(3):3043-3049. doi: 10.1007/s42770-024-01434-7. Epub 2024 Jul 1.
10
Designing molecules: directing stem cell differentiation.设计分子:引导干细胞分化
Front Bioeng Biotechnol. 2024 May 10;12:1396405. doi: 10.3389/fbioe.2024.1396405. eCollection 2024.
哺乳动物细胞层对噬菌体的摄取代表了一个可能影响噬菌体疗法的潜在吸收途径。
iScience. 2021 Mar 9;24(4):102287. doi: 10.1016/j.isci.2021.102287. eCollection 2021 Apr 23.
4
Phage Therapy: Towards a Successful Clinical Trial.噬菌体疗法:迈向成功的临床试验。
Antibiotics (Basel). 2020 Nov 19;9(11):827. doi: 10.3390/antibiotics9110827.
5
Bacteriophage Therapy for Clinical Biofilm Infections: Parameters That Influence Treatment Protocols and Current Treatment Approaches.用于临床生物膜感染的噬菌体疗法:影响治疗方案的参数及当前治疗方法
Antibiotics (Basel). 2020 Nov 12;9(11):799. doi: 10.3390/antibiotics9110799.
6
Phages versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: a Microbiological and Microbiotic Evaluation.噬菌体与抗生素治疗小鼠模型中感染性糖尿病伤口的微生物学和微生物群评估
mSystems. 2020 Nov 10;5(6):e00542-20. doi: 10.1128/mSystems.00542-20.
7
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.从美国一家中心连续治疗多药耐药细菌感染的首例10例静脉注射噬菌体疗法中吸取的经验教训。
Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa389. doi: 10.1093/ofid/ofaa389. eCollection 2020 Sep.
8
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.噬菌体治疗铜绿假单胞菌生物膜:综述。
Ann Clin Microbiol Antimicrob. 2020 Sep 30;19(1):45. doi: 10.1186/s12941-020-00389-5.
9
Phage Therapy, Lysin Therapy, and Antibiotics: A Trio Due to Come.噬菌体疗法、溶菌酶疗法与抗生素:即将到来的三联疗法。
Antibiotics (Basel). 2020 Sep 15;9(9):604. doi: 10.3390/antibiotics9090604.
10
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?噬菌体疗法在耐药时代:我们的现状与未来走向
Clin Ther. 2020 Sep;42(9):1659-1680. doi: 10.1016/j.clinthera.2020.07.014. Epub 2020 Aug 31.